Vertex Pharma Just Scored a Major FDA Approval. Is the Stock a …

4 days ago · Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to …

CouponFollow Extension

49%
OFF

Vertex Pharmaceuticals Just Won A Huge FDA Approval. Is The …

2 weeks from now

6 days ago · Vertex Pharmaceuticals (VRTX-1.49%) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up …

fool.com

62%
OFF

Vertex Pharmaceuticals Stock Rises As FDA Approves Its Pain Pill

2 weeks from now

Jan 31, 2025 · Vertex Pharmaceuticals (VRTX +0.62%) stock rose on Friday after the Food and Drug Administration (FDA) approved its new painkiller, the first of its kind approved by regulators.

qz.com

$7
OFF

FDA Approves Vertex’s Journavx As First New Pain Drug In Decades

2 weeks from now

Jan 30, 2025 · A week after Purdue Pharma and the Sackler family agreed to pay $7.4 billion to settle lawsuits stemming from the company’s opioid-based painkiller OxyContin, the FDA …

biospace.com

$461
OFF

Vertex Pharma Stock Surges After FDA Approves Non-Opioid Pain …

2 weeks from now

Jan 31, 2025 · Last November, I initiated coverage on Vertex Pharmaceutical Inc. (NASDAQ:VRTX) suggesting the stock as a strong buy around $461/share. This was due to …

seekingalpha.com

2%
OFF

Vertex Pharmaceuticals Stock Jumps After FDA Approval For New …

2 weeks from now

The approval was largely expected, but shares of Vertex jumped 5.2% early Friday. The FDA approved the drug to treat acute pain, meaning short-term pain from a procedure or injury.

msn.com

$4
OFF

Vertex Pharmaceuticals (VRTX) Set For Painless Gains After FDA …

2 weeks from now

4 days ago · All eyes are on Vertex Pharmaceuticals’ upcoming Q4 2024 results, scheduled for February 11, after the stock’s recent surge. Analysts expect earnings per share (EPS) of $4 …

businessinsider.com

3%
OFF

Vertex Stock: Maintaining Buy Despite Tempered Expectations For ...

2 weeks from now

6 days ago · Vertex (NASDAQ:VRTX) stock is down 3% since my "buy" recommendation in July, compared to S&P 500 gains of 9% during the same time. Recall that Vertex markets Trikafta, …

seekingalpha.com

$1000
OFF

Vertex Pharma Just Scored A Major FDA Approval. Is The Stock A …

2 weeks from now

That's why, following this recent FDA approval, Vertex stock makes a no-brainer biotech stock to buy and hold for the long term. Should you invest $1,000 in Vertex Pharmaceuticals right now?

theglobeandmail.com

FAQs about Vertex Pharma Just Scored a Major FDA Approval. Is the Stock a … Coupon?

Did Vertex Pharmaceuticals get FDA approval?

Vertex Pharmaceuticals (VRTX 5.31%) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating cystic fibrosis (CF). Last Thursday, the agency approved Vertex's Journavx in treating adults with moderate-to-severe acute pain. ...

Should you buy Vertex Pharmaceuticals?

The company is in the early days of a new and exciting growth story. That's why, following this recent FDA approval, Vertex stock makes a no-brainer biotech stock to buy and hold for the long term. Adria Cimino has positions in Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Vertex Pharmaceuticals. ...

Is Vertex Pharmaceuticals a no-brainer buy?

Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy? The FDA recently approved Journavx for treating acute pain. This approval is tremendously important for Vertex Pharmaceuticals. The biotech company has also received other good news over the last few weeks, and could have more on the way. ...

Should you buy vertex stock before Jan 30?

While the pending suzetrigine approval is the main reason to buy Vertex stock before Jan. 30, this FDA decision isn't the only catalyst on the way for the big biotech company. Vertex won FDA approval for its newest CF drug, Alyftrek on Dec. 20, 2024. ...

Why did Vertex Pharmaceuticals stock surge 8 % after suzetrigine approval?

Vertex Pharmaceuticals shares surged 8 % in post-market trading on January 30 after securing FDA approval for Journavx, also known as suzetrigine. The drug is the company’s first-in-class non-opioid painkiller for moderate-to-severe acute pain. ...

Why did Vertex Pharmaceuticals stock surge ahead of Friday's market open?

Shares of Vertex Pharmaceuticals Inc. surged ahead of Friday’s market open after the Food and Drug Administration approved the company’s non-opioid pain treatment. It’s the first new class of pain treatment approved in more than 20 years, Vertex said in a press statement late Thursday. ...